How Will the Veterinary Infectious Disease Diagnostics Market Grow from USD 2.67 Billion in 2026 to USD 5.12 Billion by 2034?
The global veterinary infectious disease diagnostics market size was valued at USD 2.46 billion in 2025 and is projected to grow from USD 2.67 billion in 2026 to USD 5.12 billion by 2034, registering a CAGR of 8.49% during the forecast period from 2026 to 2034. North America dominated the veterinary infectious disease diagnostics market with a market share of 38.4% in 2025.
The global veterinary infectious disease diagnostics market size was valued at USD 2.46 billion in 2025 and is projected to grow from USD 2.67 billion in 2026 to USD 5.12 billion by 2034, registering a CAGR of 8.49% during the forecast period from 2026 to 2034. North America dominated the veterinary infectious disease diagnostics market with a market share of 38.4% in 2025.
The veterinary infectious disease diagnostics market includes tests and technologies used to identify infectious diseases in animals. These tests help veterinarians detect infections using samples such as blood, tissue, and other biological materials. Common methods include immunodiagnostics and molecular diagnostics. Increasing pet ownership, growing awareness of animal health, and improvements in diagnostic technologies are supporting market growth. Early disease detection also helps veterinarians choose suitable treatments and manage infections more effectively.
Market Drivers
Growing Adoption of Pets
The growing number of pet owners is an important factor driving the veterinary infectious disease diagnostics market. Dogs and cats are increasingly treated as family members, encouraging owners to spend more on their health and well-being. Regular veterinary checkups and early disease detection are becoming important parts of responsible pet ownership.
As the number of companion animals increases, demand for veterinary consultations and diagnostic tests also rises. Infectious diseases can affect animals of different ages and may require timely testing to prevent complications. Veterinary clinics and hospitals use diagnostic tools to identify infections and support treatment decisions. These factors contribute to the growing demand for veterinary infectious disease diagnostics.
Advanced Diagnostic Devices for Animals
Advances in veterinary diagnostic technologies are supporting market development. Modern diagnostic devices help veterinarians identify infectious diseases more quickly and accurately. These technologies allow professionals to examine biological samples and identify potential disease-causing organisms.
Molecular diagnostic methods, including polymerase chain reaction (PCR), help detect genetic material associated with specific pathogens. Immunodiagnostic methods, including enzyme-linked immunosorbent assays (ELISA) and lateral flow tests, help identify antigens or antibodies related to infections.
The availability of these testing methods helps veterinary professionals select suitable diagnostic approaches for different conditions. Improvements in testing speed, accuracy, and convenience are encouraging the adoption of advanced diagnostic solutions.
Market Restraints
Increasing Cost of Pet Care
The rising cost of veterinary care can restrict market growth. Diagnostic testing, consultations, and treatment may create financial pressure for pet owners, particularly when animals require repeated examinations or specialized care.
In developing countries, limited awareness of animal healthcare and differences in access to veterinary services can also affect demand. Some pet owners may delay diagnostic testing because of cost concerns. These challenges can limit the use of veterinary infectious disease diagnostics, even when early detection is important for effective treatment.
Market Opportunities
Increasing Awareness of Animal Healthcare
Growing awareness of animal health is creating opportunities for the veterinary infectious disease diagnostics market. Pet owners are becoming more interested in preventive healthcare and the early identification of diseases. Veterinary organizations and awareness campaigns also encourage responsible pet ownership and regular health checks.
For example, the Canadian Veterinary Medical Association organizes Animal Health Week to promote animal health and responsible pet ownership. Such initiatives help educate the public about animal diseases and the importance of veterinary care.
Greater awareness can encourage more owners to seek diagnostic services when animals show symptoms of infection. This creates opportunities for diagnostic laboratories, veterinary hospitals, and companies developing animal testing technologies.
Market Segmentation
By Product
The veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and others.
Immunodiagnostics: Immunodiagnostics dominates the product segment and is projected to grow at a CAGR of 9.21% during the forecast period. These tests use interactions between antibodies and antigens to identify infectious diseases. They help veterinarians detect signs of infections caused by viruses, bacteria, and parasites.
Common immunodiagnostic methods include ELISA and lateral flow assays. These methods are used in different testing settings, depending on the disease being investigated and the required test characteristics. Some tests provide visible results and require limited sample preparation, making them useful for veterinary diagnostic applications.
Molecular Diagnostics: Molecular diagnostics includes methods such as PCR testing, which identifies genetic material associated with specific pathogens. These technologies support the detection of infectious organisms and can help veterinarians investigate suspected infections.
Others: This category includes additional diagnostic approaches used to identify infectious diseases in animals. The choice of testing method depends on the suspected infection, the sample available, and the requirements of the veterinary professional.
By Application
The market is segmented into dogs, cats, and others.
Dogs: The dog segment dominates the application category and is projected to grow at a CAGR of 9.0% during the forecast period. Dogs are among the most widely kept companion animals, and their healthcare needs contribute significantly to diagnostic demand.
Dogs can develop infectious diseases such as canine distemper, canine influenza, and parvovirus. These conditions may require prompt diagnosis and treatment. Routine veterinary examinations and growing awareness of preventive care are encouraging owners to seek diagnostic testing when necessary.
Cats: Cats also contribute to market demand because they can develop infectious diseases that require veterinary examination and testing. Diagnostic tools help veterinarians identify infections and determine appropriate treatment approaches.
Others: This category includes additional animal groups that require infectious disease testing. Demand depends on animal populations, disease risks, and access to veterinary services.
Regional Insights
North America
North America dominated the veterinary infectious disease diagnostics market, accounting for 38.4% of the market share in 2025. The region benefits from established veterinary healthcare services, increasing pet ownership, and greater awareness of companion animal health.
The availability of veterinary clinics, diagnostic laboratories, and advanced testing technologies supports market development. Pet owners are increasingly interested in early disease detection, while demand for improved veterinary care encourages the use of diagnostic products.
Europe
Europe represents an important market for veterinary infectious disease diagnostics. Growing awareness of companion animal health, research and development activities, and the availability of veterinary diagnostic services support regional demand.
The increasing need to identify infectious diseases in pets also encourages the use of diagnostic tests. Continued development of testing technologies can help veterinary professionals detect infections and improve animal healthcare.
Asia-Pacific
Asia-Pacific is projected to be the fastest-growing region, with a CAGR of 13.94% during the forecast period. Rising pet ownership, growing awareness of animal health, and increasing demand for early disease diagnosis support regional growth.
China and Australia are among the markets experiencing increased attention to companion animal healthcare. Improvements in veterinary services and greater interest in preventive treatment create opportunities for diagnostic companies.
Latin America, Middle East, and Africa
These regions offer additional opportunities as spending on animal healthcare increases. Improvements in living standards, growing awareness of animal diseases, and expanding veterinary services can support demand for diagnostic tests.
However, differences in healthcare access, affordability, and diagnostic infrastructure may affect the adoption of advanced testing technologies across individual countries.
Key Players Analysis
Key players in the veterinary infectious disease diagnostics market include:
-
bioMérieux S.A.
-
Heska Corporation
-
IDEXX Laboratories Inc.
-
IDvet
-
Indical Bioscience
-
Neogen Corporation
-
Randox Laboratories Ltd.
-
Thermo Fisher Scientific Inc.
-
Virbac
-
Zoetis Inc.
These companies participate in the market through diagnostic product development, testing technologies, and distribution networks. Competition is influenced by test accuracy, product reliability, innovation, and the ability to meet veterinary healthcare requirements.
For detailed insights, visit:
https://straitsresearch.com/report/veterinary-infectious-disease-diagnostics-market
About Us
Straits Research is a global market intelligence and consulting organization that provides industry research reports, business intelligence, and strategic insights. Its research helps businesses understand market trends, evaluate competition, and identify growth opportunities.
Contact Us
Email: [email protected]
U.S.: +1 646 905 0080
U.K.: +44 203 695 0070
Digital Marketer
Comments (0)